MUSTANG BIO, INC. Earnings Per Share, Basic and Diluted
MUSTANG BIO, INC. (MBIO) reported Earnings Per Share, Basic and Diluted of -$0.76 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-23
- MUSTANG BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.22.
- MUSTANG BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.19.
- MUSTANG BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.16.
- MUSTANG BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.19.
- MUSTANG BIO, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.76.
- MUSTANG BIO, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.14.
- MUSTANG BIO, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.29.
- MUSTANG BIO, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.14.
| Period end | Earnings Per Share, Basic and Diluted 1 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 7 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 10 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.76 10-K · filed 2022-03-23 | |||
| 2021-09-30 | -$0.19 10-Q · filed 2021-11-12 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.54 10-Q · filed 2021-11-12 | -$0.82 derived: net income ÷ weighted average shares · filed 2022-11-14 | |||
| 2021-06-30 | -$0.16 10-Q · filed 2021-08-16 | -$0.35 10-Q · filed 2021-08-16 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-08-11 | |||
| 2021-03-31 | -$0.19 10-Q · filed 2021-05-14 | -$0.49 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$0.71 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$1.01 derived: net income ÷ weighted average shares · filed 2022-05-12 | |||
| 2020-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.54 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$1.14 10-K · filed 2022-03-23 | |||
| 2020-09-30 | -$0.23 10-Q · filed 2021-11-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.82 10-Q · filed 2021-11-12 | -$1.21 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||
| 2020-06-30 | -$0.32 10-Q · filed 2021-08-16 | -$0.61 10-Q · filed 2021-08-16 | -$1.01 derived: net income ÷ weighted average shares · filed 2021-08-16 | -$1.27 derived: net income ÷ weighted average shares · filed 2021-08-16 | |||
| 2020-03-31 | -$0.28 10-Q · filed 2021-05-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$0.94 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$1.23 derived: net income ÷ weighted average shares · filed 2021-05-14 | |||
| 2019-12-31 | -$0.41 10-K · filed 2020-03-16 | -$0.66 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$0.95 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$1.29 10-K · filed 2021-03-24 | |||
| 2019-09-30 | -$0.25 10-Q · filed 2020-11-06 | -$0.54 derived: net income ÷ weighted average shares · filed 2020-11-06 | -$0.87 10-Q · filed 2020-11-06 | -$1.28 derived: net income ÷ weighted average shares · filed 2020-11-06 | |||
| 2019-06-30 | -$0.29 10-Q · filed 2020-08-10 | -$0.62 10-Q · filed 2020-08-10 | -$1.04 derived: net income ÷ weighted average shares · filed 2020-08-10 | -$1.33 derived: net income ÷ weighted average shares · filed 2020-08-10 | |||
| 2019-03-31 | -$0.34 10-Q · filed 2020-05-11 | -$0.78 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$1.05 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$1.24 derived: net income ÷ weighted average shares · filed 2020-05-11 | |||
| 2018-12-31 | -$0.43 10-K · filed 2020-03-16 | -$0.71 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.90 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$1.14 10-K · filed 2020-03-16 | |||
| 2018-09-30 | -$0.28 10-K · filed 2020-03-16 | -$0.47 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.70 10-Q · filed 2019-11-12 | -$1.29 derived: net income ÷ weighted average shares · filed 2020-03-16 | |||
| 2018-06-30 | -$0.19 10-K · filed 2020-03-16 | -$0.43 10-Q · filed 2019-08-09 | -$1.02 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$1.28 derived: net income ÷ weighted average shares · filed 2020-03-16 | |||
| 2018-03-31 | -$0.24 10-K · filed 2020-03-16 | -$0.83 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$1.10 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$1.31 derived: net income ÷ weighted average shares · filed 2020-03-16 | |||
| 2017-12-31 | -$0.61 10-K · filed 2019-03-18 | -$0.86 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.07 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.24 10-K · filed 2019-03-18 | |||
| 2017-09-30 | -$0.27 10-K · filed 2019-03-18 | -$0.48 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$0.63 10-Q · filed 2018-11-13 | -$1.10 derived: net income ÷ weighted average shares · filed 2019-03-18 | |||
| 2017-06-30 | -$0.21 10-K · filed 2019-03-18 | -$0.36 10-Q · filed 2018-08-13 | -$0.84 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.07 derived: net income ÷ weighted average shares · filed 2019-03-18 | |||
| 2017-03-31 | -$0.14 10-K · filed 2019-03-18 | -$0.66 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$0.90 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.06 derived: net income ÷ weighted average shares · filed 2019-03-18 | |||
| 2016-12-31 | -$0.64 10-K · filed 2018-03-29 | -$0.89 derived: net income ÷ weighted average shares · filed 2018-03-29 | -$1.04 derived: net income ÷ weighted average shares · filed 2018-03-29 | -$1.15 10-K · filed 2018-03-29 | |||
| 2016-09-30 | -$0.19 10-K · filed 2018-03-29 | -$0.30 derived: net income ÷ weighted average shares · filed 2018-03-29 | -$0.39 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | -$0.11 10-K · filed 2018-03-29 | -$0.20 10-Q · filed 2017-08-14 | |||||
| 2016-03-31 | -$0.09 10-K · filed 2018-03-29 | ||||||
| 2015-12-31 | -$0.09 10-K · filed 2017-03-31 | -$0.45 10-K · filed 2018-03-29 | |||||
| 2015-09-30 | -$0.07 10-K · filed 2017-03-31 | -$0.36 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$0.06 10-K · filed 2017-03-31 | ||||||
| 2015-03-31 | -$0.23 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |